Axon Enterprise, Inc. filings document operating results and corporate actions for a public safety technology company with Software & Services and Connected Devices activities. Form 8-K reports include shareholder letters on financial results and outlooks, product demand across TASER devices, Axon Body cameras, Axon Evidence, AI products, counter-drone offerings and real-time operations, as well as material-event disclosures tied to capital structure.
Proxy materials cover board composition, shareholder meeting matters, executive compensation and equity awards. Other 8-K and 8-K/A filings record director election updates and the redemption and settlement of 0.50% convertible senior notes due 2027, including the disclosure that no convertible notes remained outstanding after the redemptions and conversions.
Axon Enterprise, Inc. reported that director Julie Anne Cullivan has informed the Board that she will not stand for re-election at the company’s 2026 Annual Meeting of Shareholders. She will continue to serve as a director until her current term expires at that meeting.
The company states that Ms. Cullivan’s decision is not due to any disagreement with Axon regarding its operations, policies, or practices. The Board expressed strong appreciation for her commitment, leadership, and contributions to Axon’s growth and progress during her years of service.
Axon Enterprise president Joshua Isner reported a series of open-market stock sales. On March 10, he sold a total of 34,581 shares of Axon common stock in 18 separate transactions, at prices generally in the low-to-mid $500s per share. After these sales, he continued to hold 214,921 shares directly, so he remains a significant shareholder. The filing notes that many trades were executed in multiple lots, with reported prices representing weighted averages within specified intraday price ranges.
Axon Enterprise CEO Patrick W. Smith reported selling 10,000 shares of common stock in multiple open-market transactions on March 9, 2026. The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 12, 2025.
The trades were priced at reported weighted-average prices ranging from about $546.81 to $577.12 per share. After these transactions, Smith continues to hold 3,080,997 shares of Axon Enterprise common stock directly, indicating that the sale represents a small portion of his overall stake.
Axon Enterprise's Chief Revenue Officer, Cameron Brooks, reported an open-market sale of 1,221 shares of common stock. The shares were sold at an average price of $565.51 per share. After this transaction, Brooks directly holds about 57,545 shares, so the sale represents a small portion of his overall position. According to a footnote, the trade was executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 8, 2025, indicating it was scheduled in advance rather than timed opportunistically.
Axon reports insider sales of common stock by Patrick W. Smith. The filing lists two transactions: 01/07/2026 sale of 10,000 shares for $6,190,146.00 and 02/25/2026 sale of 10,000 shares for $5,002,400.00. The record also notes an option exercise by the issuer dated 11/15/2021 for 10,000 shares paid in cash.
Axon Enterprise’s Chief Accounting Officer, Jennifer H. Mak, reported two stock transactions. On March 2, 2026, she completed an open-market sale of 1,500 shares of common stock at $573.45 per share. On March 3, 2026, 165.956 shares were disposed of to cover tax withholding from vesting restricted stock units, a non‑open‑market transaction. Following these transactions, she directly held a little over 12,000 shares of Axon common stock.
Axon Enterprise Chief Human Officer Elizabeth Reid Coughlin reported a routine share disposition related to taxes, not an open-market trade. On this Form 4, 489.608 shares of common stock were withheld at $579.09 per share to cover tax liabilities from vesting restricted stock units. After this tax-withholding disposition, she directly held 38,979.042 shares of Axon common stock.
AXON ENTERPRISE, INC. chief revenue officer Cameron Brooks reported a tax-related share disposition. On the reported date, 764.61 shares of common stock were withheld at $579.09 per share to cover his tax liability from vesting restricted stock units. After this withholding, he directly owned 58,766.39 shares of Axon common stock.